You feel it coming.

A few days before your period — sometimes longer — something shifts. Not just physically. Something in your mind. Your mood drops off a cliff. Anxiety spikes out of nowhere. You snap at the people you love, then feel crushing guilt about it. You lie awake at 3am, convinced something is fundamentally wrong with you.

And then your period starts.

And within a day or two, you feel — remarkably, almost eerily — like yourself again.

If that pattern sounds familiar, you are not imagining it. You are not "too sensitive." You are not failing at emotional regulation. You are experiencing something real and physiological — something that has a name, a diagnostic framework, and a growing body of research behind it.

The question is: is it PMS, or is it PMDD?

That distinction matters more than most people realise. And getting it wrong — or having it dismissed — can cost women years of their lives.

Before we go any further, let's address the room.

Women have been told that premenstrual symptoms are normal for so long that many of us have internalised it. We've minimised our own experience. We've apologised for being "hormonal." We've pushed through, white-knuckled, every single month.

But here's what the research actually shows: up to 5–8% of women of reproductive age meet full clinical criteria for PMDD — a condition severe enough to significantly impair their ability to function at work, in relationships, and in daily life [1]. That is not a personality trait. That is not poor emotional regulation. That is a recognised, diagnosable disorder that responds to evidence-based treatment.

And the vast majority of those women are either misdiagnosed or never diagnosed at all.

A UK-based qualitative study found that all participants in the PMDD group had received prior misdiagnoses — most commonly major depressive disorder or generalised anxiety disorder — before anyone connected their symptoms to their cycle [2]. A report from Oxford University highlighted that GPs' knowledge of PMDD remains "very variable" and that patients frequently fall through gaps between gynaecology and mental health services [3].

You are not imagining it. Your body is trying to tell you something. The problem isn't you — it's a system that hasn't been trained to listen.

Premenstrual syndrome (PMS) is a real condition. It's not a myth, it's not weakness, and it's not something to push through without acknowledgement.

PMS describes a cluster of physical and emotional symptoms that occur cyclically in the luteal phase — the second half of the menstrual cycle, after ovulation and before menstruation. Symptoms typically appear in the one to two weeks before a period and resolve within a few days of bleeding starting.

Common PMS symptoms include:

• Bloating and breast tenderness
• Headaches or migraines
• Fatigue
• Mild irritability or mood shifts
• Food cravings
• Disrupted sleep
• Mild anxiety or low mood

Around 70–90% of women who menstruate experience some form of PMS during their reproductive years [4]. For most, symptoms are uncomfortable but manageable — they don't fundamentally disrupt daily function.

PMS doesn't have formal DSM diagnostic criteria. It's diagnosed based on symptom history, timing, and the absence of another underlying condition driving the symptoms.

PMDD — Premenstrual Dysphoric Disorder — is not a more dramatic version of PMS. It is a distinct clinical diagnosis, classified in the DSM-5 as a depressive disorder [1].

The core distinction is functional impairment. PMDD causes symptoms severe enough that they significantly disrupt the ability to work, maintain relationships, and move through daily life — and they do so consistently, every single cycle [4].

To meet DSM-5 criteria for PMDD, a woman must experience at least five of eleven specified symptoms in the week before her period starts, with at least one being a core emotional symptom, and those symptoms must resolve with — or shortly after — the onset of menstruation [1].

The four core emotional symptoms are:

• Markedly depressed mood, feelings of hopelessness, or self-deprecating thoughts
• Marked anxiety, tension, or feeling keyed up or on edge
• Marked affective lability (sudden mood shifts, feeling suddenly sad or tearful, increased sensitivity to rejection)
• Persistent and marked irritability, anger, or increased interpersonal conflict

Additional symptoms that can count toward the five include: difficulty concentrating, fatigue or low energy, changes in appetite or food cravings, sleep disturbances, feeling overwhelmed or out of control, and physical symptoms such as breast tenderness, joint pain, or bloating.

Here's the critical part: the symptoms must also be confirmed across at least two menstrual cycles via prospective daily tracking — meaning you record them as they happen, not retrospectively [1]. This is what distinguishes a confirmed PMDD diagnosis from a provisional one, and it's why tracking your cycle is not optional if you want answers.

This is one of the most important parts of this article, and one of the most infuriating.

PMDD is cyclical. Its symptoms are real and severe in the luteal phase, and then they disappear. Which means that when a woman goes to her GP at a random point in her cycle, she may appear relatively well. She describes anxiety, low mood, rage, intrusive thoughts. She's given a depression or anxiety diagnosis. She's prescribed antidepressants — without anyone asking when in her cycle she feels this way.

The critical diagnostic question — "Do your symptoms follow a pattern in relation to your period?" — is often never asked.

Women have reported bringing cycle-tracking evidence to appointments and still being dismissed. Some have been told their symptoms are due to personality disorders, chronic fatigue, or simply being "sensitive" [2].

The problem isn't only awareness. It's also structural. PMDD sits at the intersection of gynaecology and psychiatry, and neither specialty has historically claimed full ownership of it. Women fall into the gap between the two.

This is what makes self-education so powerful. Understanding the cyclical pattern of your symptoms — and being able to articulate it clearly with tracked data — is often what finally gets a woman taken seriously.

This is where it gets genuinely interesting — and where a lot of the outdated "it's just hormones" narrative falls apart.

PMDD is not caused by abnormal hormone levels. Women with PMDD typically have normal progesterone and oestrogen levels. The difference is not the hormones themselves — it's how the brain responds to them [5].

Here's the mechanism. After ovulation, progesterone rises significantly during the luteal phase. As the body metabolises progesterone, it produces a neurosteroid called allopregnanolone. In most women, allopregnanolone has a calming, sedative effect — it enhances the function of GABA receptors, which are the brain's primary inhibitory system. Think of GABA as the nervous system's brake pedal.

In women with PMDD, the brain appears to be abnormally sensitive to allopregnanolone fluctuations — and rather than a calming effect, the rising and then rapidly falling levels of this neurosteroid in the late luteal phase cause destabilisation of mood, anxiety, and emotional regulation [5, 6].

Simultaneously, serotonin — the neurotransmitter most closely associated with mood stability — shows reduced availability in the late luteal phase in women with PMDD, which is why SSRIs (selective serotonin reuptake inhibitors) are one of the most effective first-line treatments, and why they can even work when taken only during the luteal phase [5].

This is not a character flaw. This is not poor coping. This is a neurological sensitivity to normal hormonal change. The hormones are doing what they are supposed to do. The brain's response is the variable.

If you recognise yourself in the description of PMDD, the most important thing you can do right now is start tracking.

The gold standard diagnostic tool is the Daily Record of Severity of Problems (DRSP) — a validated daily rating scale that maps symptoms across the cycle and establishes the on-off pattern that confirms PMDD versus other mood conditions [1].

You don't need a clinical tool to start. A simple daily log noting date, cycle day, and symptom severity on a 1–5 scale is a good beginning. What you're looking for:

Signs that point toward PMDD rather than PMS or a generalised mood disorder:

1. A clear symptom-free window mid-cycle — typically from the end of your period through ovulation. If you feel relatively stable and like yourself during this window, that is significant.

2. A reliable onset pattern — symptoms appearing consistently in the second half of your cycle (usually from ovulation onward, or more specifically in the week before your period).

3. Rapid resolution with menstruation — symptoms lifting within one to two days of bleeding starting, often dramatically.

4. Functional impairment — symptoms affecting your ability to work, be present in relationships, or move through daily life in a way that mild PMS does not.

5. Emotional symptoms are the dominant feature — not just physical discomfort, but psychological distress that feels genuinely out of proportion to your life circumstances.

Track across at least two full cycles before drawing conclusions. Take that data to your GP or a specialist with an interest in hormonal mood conditions.

Clinical criteria are important. But so is saying clearly what this condition actually does to a person's life.

Women with PMDD often describe it as living two lives. One version of themselves is capable, present, high-functioning, connected. The other version — the one that arrives reliably in the week or two before their period — feels like a completely different person. Anxious, rageful, hopeless, withdrawn. Convinced that their relationships are failing, their career is falling apart, their life is wrong.

And then the period starts.

And they feel fine.

The grief of that cycle is its own particular kind of suffering. The guilt about things said or felt during the luteal phase. The fear that the person who shows up each month will eventually damage something irreparable. The exhaustion of white-knuckling through it, month after month, without understanding why it's happening.

You're not imagining it. Your diagnosis is a starting point, not a verdict. Understanding what is driving those symptoms is how you begin to build something more stable.

Knowing whether you're dealing with PMS or PMDD matters for several reasons.

Treatment differs significantly. PMS can often be meaningfully improved with nutritional support, stress regulation, sleep hygiene, and targeted supplementation. PMDD, in more severe cases, may also require SSRIs (often in luteal-phase-only dosing), hormonal interventions, or CBT specifically adapted for PMDD.

Misdiagnosis delays appropriate care. Women treated for generalised depression or anxiety without addressing the cyclical hormonal driver often see limited improvement — because the root cause hasn't been addressed.

Understanding the mechanism reduces shame. The PMDD brain is not broken. It is responding differently to a normal process. That distinction — between a character flaw and a neurobiological reality — matters enormously to how a woman relates to her own experience.

It gives you something to work with. Once you understand the cyclical pattern, you can build a strategy around it — tracking the luteal phase, adjusting demands and social commitments where possible, working with targeted support for stress regulation and mood stability.

A PMDD diagnosis is not the end of the conversation — it's the beginning of building a practical, evidence-led approach.

For women managing the hormonal drivers that contribute to luteal phase symptoms, nutritional and botanical support can play a meaningful supporting role alongside (not instead of) appropriate medical care.

Key areas to consider:

• Stress and cortisol regulation — elevated cortisol in the luteal phase amplifies every mood symptom. Adaptogens like KSM-66® Ashwagandha have clinical evidence for cortisol modulation and stress resilience [read our full Ashwagandha guide].
• Nervous system support — botanicals with GABA-adjacent activity, including Chamomile and Holy Basil, may support the nervous system during the luteal phase when allopregnanolone fluctuations are most destabilising.
• Serotonin pathway support — Vitamin B6 in its active form (Pyridoxal-5-Phosphate) is directly involved in the synthesis of serotonin and dopamine, the neurotransmitters most disrupted in PMDD.
• Inflammation reduction — emerging research suggests a neuroinflammatory component in PMDD; anti-inflammatory nutritional strategies can form a meaningful part of a broader support plan [read our anti-inflammatory eating guide].
• Sleep quality — poor sleep worsens every luteal phase symptom, full stop.

The MyOva Cycle Support Supplement has been specifically formulated with the PMDD and severe PMS audience in mind. Here's why each ingredient is relevant to what's actually happening in the luteal phase:

• KSM-66® Ashwagandha — an extensively studied adaptogen with clinical evidence for reducing cortisol and improving stress resilience. Elevated cortisol in the luteal phase amplifies every PMDD symptom; this is one of the most directly relevant ingredients in the formula.
• Griffonia Simplicifolia (30% 5-HTP) — 5-hydroxytryptophan is a direct precursor to serotonin, the neurotransmitter most dysregulated in PMDD. Supporting serotonin synthesis through the luteal phase addresses one of the core neurological mechanisms involved.
• Pyridoxal 5'-Phosphate (active B6) — the active form of Vitamin B6, directly involved in the conversion of 5-HTP to serotonin and in dopamine synthesis. Critically, it's in the P5P form — the bioavailable form the body can actually use without conversion.
• Green Tea Extract (60% L-Theanine) — L-Theanine promotes calm alertness and has evidence for reducing anxiety without sedation. In the context of luteal phase anxiety and hyperarousal, this is a meaningful addition.
• Rhodiola Rosea (3% Rosavin) — a well-researched adaptogen with evidence for fatigue reduction and mood stability, particularly relevant for the emotional exhaustion and low mood that characterises PMDD's luteal phase.
• Chamomile Extract — supports nervous system calm through GABA-adjacent pathways — directly relevant to the allopregnanolone-GABA dysregulation that underpins PMDD.
• Broccoli Extract (5% Sulforaphane) — supports oestrogen metabolism and detoxification pathways via the liver, helping to reduce oestrogen dominance that can exacerbate luteal phase symptoms.
• Turmeric (95% Curcuminoids) — addresses the neuroinflammatory component of PMDD, which emerging research increasingly recognises as a contributing driver of mood and psychological symptoms in the luteal phase.

It is not a treatment for PMDD. It is not a replacement for medical care. But for women looking to support the specific neurological and hormonal pathways disrupted in PMDD — while working toward a diagnosis or alongside medical management — it is one of the most targeted formulations available.

→ Explore the MyOva Cycle Support Supplement

→ Read: Why Your Hormones Feel Off — And What to Do About It

→ Read: Red Clover for Menopause: Plant Oestrogen or Overhyped Herb?

If you recognise PMDD in your experience, these are the practical next steps:

Track first. Two cycles of daily symptom data — with severity ratings and cycle day — before your appointment. Bring it with you.

Ask specifically about PMDD. Not "I feel bad before my period" but "I believe my symptoms are cyclical, consistent with a luteal phase onset and rapid resolution at menstruation, and I'd like to discuss PMDD."

Ask for a referral if needed. GPs with limited PMDD experience may refer you to a gynaecologist with a specialist interest, or to a psychiatrist who understands reproductive mood disorders.

Know your options exist. Luteal-phase SSRI dosing, GnRH analogues for severe cases, CBT adapted for PMDD, and nutritional and lifestyle strategies are all part of the evidence base. You do not have to simply endure this.

If you are in crisis: If PMDD is causing thoughts of self-harm or suicide — which is more common in PMDD than is widely acknowledged — please contact your GP urgently, call 111, or reach Samaritans on 116 123, available 24 hours a day. You deserve immediate support.

PMS and PMDD are not the same thing.

PMS is common, uncomfortable, and real. PMDD is a clinical diagnosis, a neurobiological condition, and a significant disruptor of quality of life for the women who experience it.

The difference between them is not about toughness. It is not about sensitivity. It is about the brain's response to normal hormonal fluctuations — and that response can be investigated, understood, and addressed.

If you have spent years assuming your luteal phase symptoms are just "bad PMS," it is worth asking the question properly. Track your cycle. Document the pattern. Take that data to a clinician who understands what to do with it.

You are not imagining it.

Your symptoms follow a pattern for a reason.

And understanding that reason is the beginning of building something better.

Can I have PMDD if I have regular periods? Yes. PMDD is not about irregular cycles. It's about the brain's response to normal hormonal fluctuations in the luteal phase. Women with regular, predictable cycles can and do have PMDD.

How is PMDD different from depression? The key distinguishing feature is cyclicality and a symptom-free window. Depression typically persists across the entire cycle. PMDD symptoms are confined to the luteal phase and resolve with menstruation. That said, the two can co-exist, which makes accurate tracking essential [4].

Does the pill help PMDD? It depends on the type. Some combined oral contraceptives — particularly those containing drospirenone — have evidence for PMDD symptom reduction. Other formulations can worsen symptoms. This is a conversation to have with your GP or gynaecologist.

Can PMDD get worse over time? For some women, yes — particularly following pregnancy, childbirth, or perimenopause, when hormonal fluctuations intensify. This is not inevitable, but it is a reason to take symptoms seriously and seek support early [1].

Is PMDD genetic? Research suggests PMDD may be 30–80% heritable, though specific genetic contributors haven't been fully characterised [6]. A family history of depression, anxiety, or mood disorders can increase risk.

Can lifestyle changes make a difference? Yes — particularly for stress regulation, sleep quality, blood sugar stability, and anti-inflammatory nutrition. These support the hormonal and neurological pathways involved in PMDD and can reduce symptom severity, though they are rarely sufficient alone in moderate to severe cases.

This article is for educational purposes only and does not constitute medical advice. If you believe you may be experiencing PMDD, please speak with your GP or a qualified healthcare professional. If you are having thoughts of self-harm, please contact Samaritans on 116 123 (free, 24/7) or your GP urgently.

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th Edition (DSM-5). Washington, DC: APA; 2013. Premenstrual Dysphoric Disorder criteria (pp. 171–175).

2. Pradhan A. Pardon my sobbing: a qualitative study on differentiating generalised mood disorders from premenstrual dysphoric disorder. BJPsych Open. 2022;8(4):e128. doi:10.1192/bjo.2022.235

3. Timäus C, Meiser M, Mühlbauer E, et al. New data shows prevalence of premenstrual dysphoric disorder. Journal of Affective Disorders. 2024. University of Oxford press release, January 2024.

4. Epperson CN, Steiner M, Hartlage SA, et al. Premenstrual dysphoric disorder: evidence for a new category for DSM-5. Am J Psychiatry. 2012;169(5):465–475. doi:10.1176/appi.ajp.2012.11081302

5. Bixo M, Ekberg K, Poromaa IS, et al. Allopregnanolone in premenstrual dysphoric disorder (PMDD): evidence for dysregulated sensitivity to GABA-A receptor modulating neuroactive steroids across the menstrual cycle. Neuroscience & Biobehavioral Reviews. 2020;115:214–225. doi:10.1016/j.neubiorev.2020.02.003

6. Hantsoo L, Epperson CN. Towards understanding the biology of premenstrual dysphoric disorder: from genes to GABA. Neuroscience & Biobehavioral Reviews. 2020;115:252–268. doi:10.1016/j.neubiorev.2020.02.025